BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 322.60
+6.80 (2.15%)
Jul 28, 2026, 5:29 PM CET
BioArctic AB Employees
BioArctic AB had 141 employees as of March 31, 2026. The number of employees increased by 12 or 9.30% since the number was last reported on December 31, 2025.
Employees
141
Change
12
Growth
9.30%
Revenue / Employee
8.14M SEK
Profits / Employee
1.51M SEK
Market Cap
28.02B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 141 | 12 | 9.30% |
| Dec 31, 2025 | 129 | 22 | 20.56% |
| Dec 31, 2024 | 107 | 19 | 21.59% |
| Dec 31, 2023 | 88 | 27 | 44.26% |
| Dec 31, 2022 | 61 | 12 | 24.49% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Camurus AB | 316 |
| Hansa Biopharma AB | 122 |
| BioInvent International AB | 112 |
| Egetis Therapeutics AB | 44 |
| Saniona AB | 43 |
| Vicore Pharma Holding AB | 40 |
| Genovis AB (publ.) | 36 |
| SynAct Pharma AB | 8 |
BioArctic AB News
- 14 days ago - More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026 - PRNewsWire
- 14 days ago - FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease - PRNewsWire
- 15 days ago - New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease - PRNewsWire
- 4 weeks ago - New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026 - PRNewsWire
- 5 weeks ago - BioArctic AB Press release: Collaboration - Filings
- 5 weeks ago - BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology - PRNewsWire
- 2 months ago - Number of shares and votes in BioArctic AB (publ) as of May 29, 2026 - PRNewsWire
- 2 months ago - Bulletin from the Annual General Meeting in BioArctic AB (publ) - PRNewsWire